Howard OM - Search Results

1

Chemokines: progress toward identifying molecular targets for therapeutic agents.

Howard OM, Ben-Baruch A, Oppenheim JJ. Howard OM, et al. Trends Biotechnol. 1996 Feb;14(2):46-51. doi: 10.1016/0167-7799(96)80920-6. Trends Biotechnol. 1996. PMID: 8746116 Review.

2

Chemokines as molecular targets for therapeutic intervention.

Howard OM, Oppenheim JJ, Wang JM. Howard OM, et al. J Clin Immunol. 1999 Sep;19(5):280-92. doi: 10.1023/a:1020587407535. J Clin Immunol. 1999. PMID: 10535604 Free PMC article. Review.

3

The differential ability of IL-8 and neutrophil-activating peptide-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8 receptor B).

Ben-Baruch A, Grimm M, Bengali K, Evans GA, Chertov O, Wang JM, Howard OM, Mukaida N, Matsushima K, Oppenheim JJ. Ben-Baruch A, et al. Among authors: howard om. J Immunol. 1997 Jun 15;158(12):5927-33. J Immunol. 1997. PMID: 9190946

4

Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication.

Gong W, Howard OM, Turpin JA, Grimm MC, Ueda H, Gray PW, Raport CJ, Oppenheim JJ, Wang JM. Gong W, et al. Among authors: howard om. J Biol Chem. 1998 Feb 20;273(8):4289-92. doi: 10.1074/jbc.273.8.4289. J Biol Chem. 1998. PMID: 9468473 Free article.

5

Opiate inhibition of chemokine-induced chemotaxis.

Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Wang JM, Oppenheim JJ. Grimm MC, et al. Among authors: howard om. Ann N Y Acad Sci. 1998 May 1;840:9-20. doi: 10.1111/j.1749-6632.1998.tb09544.x. Ann N Y Acad Sci. 1998. PMID: 9629232 Review.

6

Small molecule inhibitor of HIV-1 cell fusion blocks chemokine receptor-mediated function.

Howard OM, Korte T, Tarasova NI, Grimm M, Turpin JA, Rice WG, Michejda CJ, Blumenthal R, Oppenheim JJ. Howard OM, et al. J Leukoc Biol. 1998 Jul;64(1):6-13. doi: 10.1002/jlb.64.1.6. J Leukoc Biol. 1998. PMID: 9665268 Review.

7

HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.

Wang JM, Ueda H, Howard OM, Grimm MC, Chertov O, Gong X, Gong W, Resau JH, Broder CC, Evans G, Arthur LO, Ruscetti FW, Oppenheim JJ. Wang JM, et al. Among authors: howard om. J Immunol. 1998 Oct 15;161(8):4309-17. J Immunol. 1998. PMID: 9780207

8

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ. Salcedo R, et al. Among authors: howard om. Am J Pathol. 1999 Apr;154(4):1125-35. doi: 10.1016/s0002-9440(10)65365-5. Am J Pathol. 1999. PMID: 10233851 Free PMC article.

9

Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function.

Howard OM, Shirakawa AK, Turpin JA, Maynard A, Tobin GJ, Carrington M, Oppenheim JJ, Dean M. Howard OM, et al. J Biol Chem. 1999 Jun 4;274(23):16228-34. doi: 10.1074/jbc.274.23.16228. J Biol Chem. 1999. PMID: 10347178 Free article.

10

Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6.

Yang D, Howard OM, Chen Q, Oppenheim JJ. Yang D, et al. Among authors: howard om. J Immunol. 1999 Aug 15;163(4):1737-41. J Immunol. 1999. PMID: 10438902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page